Association between state Medicaid policies and accrual of Black and Hispanic patients to cancer clinical trials. - ASCO Home / Posters / Disclaimer ...

The Oncology Evaluation Center: Implementation of a same-day evaluation and treatment center to avoid unnecessary ED visits. - ASCO Home / Posters / Disclaimer ...

Randomized phase II study of S-1 monotherapy versus gemcitabine plus S-1 in gemcitabine-refractory advanced pancreatic cancer. - ASCO Home / Posters / Disclaimer ...

Incidence, characteristics, and survival of patients with <I>EGFR</I>-mutant lung cancers with <I>EGFR T790M</I> at diagnosis identified in the lung cancer mutation consortium (LCMC). - ASCO Home / ...

Efficacy and safety of encorafenib (enco) plus binimetinib (bini) in patients with <em>BRAF</em> V600E-mutant (<em>BRAF</em>^V600E) metastatic non-small ...

Initial experience with an innovative pilot program evaluating a multidisciplinary approach to supportive care planning in a survivorship clinic setting. - ASCO Home / Posters / Disclaimer ...

Sequential immunotherapy in rare variant renal cell carcinomafinal report of UNISoN (ANZUP 1602): Nivolumab then ipilimumab + nivolumab in advanced nonclear cell renal cell carcinoma. - ASCO Home / ...

The influence of polypharmacy on grade III/IV toxicity, prior discontinuation of chemotherapy and survival in recurrent ovarian cancer patients: An individual participant data meta-analysis of the ...

Sign in to explore collection of abstracts, journal articles, posters, videos, and slides.

Sign in to explore collection of abstracts, journal articles, posters, videos, and slides.

Guideline adherence rates and costs of chemotherapy treatment for NSCLC patients treated in U.S. community oncology practices. - ASCO Home / Posters / Disclaimer ...

Impact of 68Ga-PSMA-11 PET/CT on staging and management of prostate cancer patients in various clinical settings. - ASCO Home / Posters / Disclaimer ...